2023-01-27 20:18:00

Dr. Rohit Varma Shares Eye-Disease Research at the 2nd Mexico-United States Symposium on Vision Health

Logo Benzinga
By Business Wire

More than 40 leading ophthalmologists, vision researchers, and public health/policy experts are sharing data and holding discussions on the global burden of diabetes-related eye disease to develop a plan to address this leading cause of blindness at the 2nd Mexico-U.S. Symposium on Vision Health.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230127005421/en/

An internationally acclaimed clinician and epidemiologist, Dr. Rohit Varma is the world's foremost expert on eye disease in Latinos. (Photo: Business Wire)

The Symposium is a partnership between the Government of Mexico and the United States Department of Health and Human Services (HHS), National Institutes of Health (NIH), and National Eye Institute (NEI). It is co-chaired by Dr. Maria Julia Marinissen, Health Attach, U.S. Embassy Mexico City; Acting Director, U.S. Section Border Health Commission, HHS; Dr. Van Charles Lansingh, Chief Medical Officer, HelpMeSee; Director of Research, "Instituto Mexicano de Oftalmologa (IMO);" Voluntary Associate Professor of Ophthalmology and Department of Public Health Sciences, University of Miami Miller School of Medicine; and Dr. Gyan "John" Prakash, Director, Office of International Program Activities, NIH/NEI.

Continue read on benzinga.com

Logo EIN Presswire
HealthPress Release2023-01-27 10:28:13
Diabetic Retinopathy Market Trends Diabetic retinopathy (DR) is an eye disease associated with diabetic patients. The disease occurs when there is damage to...

Logo NewsFileCorp
Press Release2023-01-27 12:00:00
San Diego, California--(Newsfile Corp. - January 27, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company...

Logo EIN Presswire
HealthPress Release2023-01-27 11:03:12
Eye Inflammation Treatment Market Infections, allergies, autoimmune diseases, irritation, injuries, or damage to the eyes, eyelids, or surrounding tissues...

EconomyBy Goh Chiew Tong2023-01-27 01:37:27
Its devices assess cardiovascular risk through the use of retinal imagery and artificial intelligence a first of its kind, Mediwhale told CNBC Make It.

Logo GlobeNewswire
SciencePress Release2023-01-25 21:01:00
Oral APX3330 Achieved Statistical Significance on a Key Pre-specified Secondary Endpoint of Preventing Clinically Meaningful Progression of Diabetic...

Logo PR Newswire
HealthPress Release2023-01-27 01:01:00
SAN FRANCISCO, Jan. 27, 2023 /PRNewswire/ -- Glaucoma Research Foundation (GRF) will host the 12 th Annual Glaucoma 360 New Horizons Forum on February 3rd at...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-25 12:30:00
Session to have special translational research emphasis on PRPH2 and inherited macular dystrophies. COLUMBIA, Md., Jan. 25, 2023 /PRNewswire/ --The...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-27 18:00:00
The Association for Education and Rehabilitation of the Blind and Visually Impaired (AER), is excited to announce that the first issue of its new...

Logo GlobeNewswire
HealthPress Release2023-01-26 13:30:00
Over 1,000 Professional Eye Care Practices Have integrated the TearCare Systemto Treat Root Cause of Dry Eye Disease due to Meibomian Gland Dysfunction (MGD)...

Logo GlobeNewswire
EconomyPress Release2023-01-27 15:00:00
Advancements in 3D technology regarding car night vision system serves as a potential opportunity for the expansion of the global car night vision system...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-27 13:57:00
National Federation of the Blind Seeks to Advance Legislative Priorities WASHINGTON, Jan. 27, 2023 /PRNewswire/ -- Next week, hundreds of blind Americans...

Logo EIN Presswire
HealthPress Release2023-01-27 06:47:49
Research Nester Diabetic footwear (shoes) market is estimated to garner a revenue of ~USD 18 Billion by the end of 2033 by growing at a CAGR of ~11% NEW...

Logo Nasdaq
Business / FinanceBy The Motley Fool2023-01-27 13:45:00
Last month, Novartis (NYSE: NVS) revealed encouraging results from a phase 3 clinical trial of the rare-disease drug candidate known as iptacopan for adult...

Logo GlobeNewswire
HealthPress Release2023-01-27 17:00:00
Extraordinary General Meeting of February 15, 2023: Notice of publication of the preparatory documents Paris, France, January 27, 2023 6.00 pm CET Pixium...

Logo EIN Presswire
HealthPress Release2023-01-27 07:08:13
Medical Illumination Systems Market Medical illumination systems are devices used to assist doctors during surgical procedures and examination of patients,...

Logo PR Newswire
HealthPress Release2023-01-16 11:45:00
DUBLIN, Jan. 16, 2023 /PRNewswire/ -- The "Diabetic Macular Edema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends,...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-26 09:50:00
More funding, political will and collaboration needed to continue the fight against neglected tropical diseases Simple treatments can protect people from...

Logo PR Newswire
HealthPress Release2023-01-27 13:33:00
Colonel (Retired) Dallas Hack, MD, MPH of Neurologics NEWPORT BEACH, Calif., Jan. 27, 2023 /PRNewswire/ -- With several high-profile injuries taking place...

Logo The Business Journals
Technology2023-01-27 13:51:28
Photodigm announced the rollout of a new tiered pr

Logo PR Newswire
HealthPress Release2023-01-27 15:30:00
PITTSBURGH, Jan. 27, 2023 /PRNewswire/ -- "I wanted to create a new article of PPE to protect the eyes and to prevent optical lenses from fogging up," said...